The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy
Clinical trial NCT02944604 · COMPLETED
Trial details
- NCT number
- NCT02944604
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-08
- Primary completion
- 2017-09-29
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.